Head-to-Head Comparison of [ 18 F]PSMA-1007 and [ 18 F]FDG PET/CT in Patients with Triple-Negative Breast Cancer.
Natalia AndryszakDaria ŚwiniuchElżbieta WójcikRodryg RamlauMarek RuchalaRafał CzepczyńskiPublished in: Cancers (2024)
F]PSMA-1007 PET/CT in enhancing both diagnostic and therapeutic approaches for this aggressive breast cancer subtype.